Faraz Choudhury

Faraz A. Choudhury, PhD is the president and CEO of Immuto Scientific. Dr. Choudhury co-founded Immuto Scientific in 2018 along with a team of world renowned researchers from the University of Wisconsin- Madison. Dr. Choudhury is one of the inventors of Immuto Scientific's core technology- PLIMB and he has been involved in the design, development and application of the technology from the inception. His doctorate research work focused on developing plasma technologies for semiconductor manufacturing as well as biological applications. After completing his postdoctoral training, he worked several years as a Research Scientist in the Department of Biochemistry at the University of Wisconsin- Madison (UW Madison). His research focused on proteomics, epitope mapping and protein-­protein interactions studies using mass spectrometry. Dr. Choudhury served as a Principal Investigator (PI) on two grants and has been involved as co-investigator or contributor to several other grants from NIH, NSF, NIFA, WARF and WEDC totaling over $1.4M. He administered the projects, developed research plans, collaborated with other researchers, and produced several peer-­reviewed publications and two patents. Dr. Choudhury is spearheading the commercialization efforts as the President and CEO of Immuto Scientific, a contract research organization (CRO) based in Madison, WI that is developing breakthrough technologies to advance drug discovery. The company has two locations in Madison, WI- one in Research Park and a second 4000 sqft lab facility near the Dane County Airport. Immuto Scientific provides analytical research services for drug discovery including epitope/paratope mapping, protein-protein interaction studies, protein-small molecule drug binding studies, protein folding and conformation analysis and protein structural characterization. Immuto Scientific’s customers include the top 5 pharmaceutical companies in the US as well as several pre-clinical and clinical stage biotechnology companies.